Prognostic Biomarkers Related to Breast Cancer Recurrence Identified Based on Logit Model Analysis

Overview

Journal World J Surg Oncol

Publisher Biomed Central

Specialties General Surgery
Oncology

Date 2020 Sep 26

PMID 32977823

Citations 16

Authors

Xiaoying Zhou

Chuanguang Xiao

Tong Han

Shusheng Qiu

Meng Wang

Jun Chu

Weike Sun

Liang Li

Lili Lin

Affiliations

Soon will be listed here.

Abstract

Background: This study intended to determine important genes related to the prognosis and recurrence of breast cancer.

Methods: Gene expression data of breast cancer patients were downloaded from TCGA database. Breast cancer samples with recurrence and death were defined as poor disease-free survival (DFS) group, while samples without recurrence and survival beyond 5 years were defined as better DFS group. Another gene expression profile dataset (GSE45725) of breast cancer was downloaded as the validation data. Differentially expressed genes (DEGs) were screened between better and poor DFS groups, which were then performed function enrichment analysis. The DEGs that were enriched in the GO function and KEGG signaling pathway were selected for cox regression analysis and Logit regression (LR) model analysis. Finally, correlation analysis between LR model classification and survival prognosis was analyzed.

Results: Based on the breast cancer gene expression profile data in TCGA, 540 DEGs were screened between better DFS and poor DFS groups, including 177 downregulated and 363 upregulated DEGs. A total of 283 DEGs were involved in all GO functions and KEGG signaling pathways. Through LR model screening, 10 important feature DEGs were identified and validated, among which, ABCA3, CCL22, FOXJ1, IL1RN, KCNIP3, MAP2K6, and MRPL13, were significantly expressed in both groups in the two data sets. ABCA3, CCL22, FOXJ1, IL1RN, and MAP2K6 were good prognostic factors, while KCNIP3 and MRPL13 were poor prognostic factors.

Conclusion: ABCA3, CCL22, FOXJ1, IL1RN, and MAP2K6 may serve as good prognostic factors, while KCNIP3 and MRPL13 may be poor prognostic factors for the prognosis of breast cancer.

Citing Articles

Single-Cell RNA Sequencing on Formalin-Fixed and Paraffin-Embedded (FFPE) Tissue Identified Multi-Ciliary Cells in Breast Cancer.

Gonzalez-Martinez S, Palacios J, Carretero-Barrio I, Lanza V, Garcia-Cosio Piqueras M, Caniego-Casas T Cells. 2025; 14(3).

PMID: 39936988 PMC: 11816443. DOI: 10.3390/cells14030197.

LncRNA TCL6 regulates miR-876-5p/MYL2 axis to suppress breast cancer progression.

Liu Y, Li H, Chai D, Lian B, Bai Z, Gao Y Transl Oncol. 2025; 53:102210.

PMID: 39874729 PMC: 11810844. DOI: 10.1016/j.tranon.2024.102210.

Revelation of comprehensive cell profiling of primary and metastatic tumour ecosystems in oral squamous cell carcinoma by single-cell transcriptomic analysis.

Liao Y, Chen L, Feng B, Lv W, Huang X, Li H Int J Med Sci. 2024; 21(12):2293-2304.

PMID: 39310253 PMC: 11413902. DOI: 10.7150/ijms.97404.

Identification of Breast Cancer Subtypes Based on Endoplasmic Reticulum Stress-Related Genes and Analysis of Prognosis and Immune Microenvironment in Breast Cancer Patients.

Yi C, Yang J, Zhang T, Qin L, Chen D Technol Cancer Res Treat. 2024; 23:15330338241241484.

PMID: 38725284 PMC: 11085026. DOI: 10.1177/15330338241241484.

In silico analyses of pan-squamous cell carcinoma unveiled the immunological implications of MRPL13, which had previously been under-recognized.

Liang Y, He S, Tan Y, Liu Q, Zhao F, Liu T Heliyon. 2024; 10(1):e23582.

PMID: 38187248 PMC: 10770563. DOI: 10.1016/j.heliyon.2023.e23582.

References

Knauer M, Mook S, Rutgers E, Bender R, Hauptmann M, van de Vijver M . The predictive value of the 70-gene signature for adjuvant chemotherapy in early breast cancer. Breast Cancer Res Treat. 2010; 120(3):655-61. DOI: 10.1007/s10549-010-0814-2. View

Cheadle C, Vawter M, Freed W, Becker K . Analysis of microarray data using Z score transformation. J Mol Diagn. 2003; 5(2):73-81. PMC: 1907322. DOI: 10.1016/S1525-1578(10)60455-2. View

Li Y, Liu F, Zhang X, Guo X, Ren M, Fu L . Tumor secretion of CCL22 activates intratumoral Treg infiltration and is independent prognostic predictor of breast cancer. PLoS One. 2013; 8(10):e76379. PMC: 3790712. DOI: 10.1371/journal.pone.0076379. View

Mehta S, Shelling A, Muthukaruppan A, Lasham A, Blenkiron C, Laking G . Predictive and prognostic molecular markers for cancer medicine. Ther Adv Med Oncol. 2011; 2(2):125-48. PMC: 3126011. DOI: 10.1177/1758834009360519. View

Wang D, Done S, Mc Cready D, Leong W . Validation of the prognostic gene portfolio, ClinicoMolecular Triad Classification, using an independent prospective breast cancer cohort and external patient populations. Breast Cancer Res. 2014; 16(4):R71. PMC: 4226941. DOI: 10.1186/bcr3686. View

Zhou M, Zhong L, Xu W, Sun Y, Zhang Z, Zhao H . Discovery of potential prognostic long non-coding RNA biomarkers for predicting the risk of tumor recurrence of breast cancer patients. Sci Rep. 2016; 6:31038. PMC: 4977495. DOI: 10.1038/srep31038. View

Mints M, Mushtaq M, Iurchenko N, Kovalevska L, Stip M, Budnikova D . Mitochondrial ribosomal protein S18-2 is highly expressed in endometrial cancers along with free E2F1. Oncotarget. 2016; 7(16):22150-8. PMC: 5008351. DOI: 10.18632/oncotarget.7905. View

Parray A, Anjum Baba R, Bhat H, Wani L, Mokhdomi T, Mushtaq U . MKK6 is upregulated in human esophageal, stomach, and colon cancers. Cancer Invest. 2014; 32(8):416-22. DOI: 10.3109/07357907.2014.933236. View

Hendrick R . Radiation doses and cancer risks from breast imaging studies. Radiology. 2010; 257(1):246-53. DOI: 10.1148/radiol.10100570. View

10.

Nishikawa H, Sakaguchi S . Regulatory T cells in tumor immunity. Int J Cancer. 2010; 127(4):759-67. DOI: 10.1002/ijc.25429. View

11.

Ji C, Lin S, Yao D, Li M, Chen W, Zheng S . Identification of promising prognostic genes for relapsed acute lymphoblastic leukemia. Blood Cells Mol Dis. 2019; 77:113-119. DOI: 10.1016/j.bcmd.2019.04.010. View

12.

Worst T, Reiner V, Gabriel U, Weiss C, Erben P, Martini T . IL1RN and KRT13 Expression in Bladder Cancer: Association with Pathologic Characteristics and Smoking Status. Adv Urol. 2014; 2014:184602. PMC: 4119623. DOI: 10.1155/2014/184602. View

13.

Diaz-Romero J, Romeo S, Bovee J, Hogendoorn P, Heini P, Mainil-Varlet P . Hierarchical clustering of flow cytometry data for the study of conventional central chondrosarcoma. J Cell Physiol. 2010; 225(2):601-11. DOI: 10.1002/jcp.22245. View

14.

Demircan B, Dyer L, Gerace M, Lobenhofer E, Robertson K, Brown K . Comparative epigenomics of human and mouse mammary tumors. Genes Chromosomes Cancer. 2008; 48(1):83-97. PMC: 2929596. DOI: 10.1002/gcc.20620. View

15.

Wang P, Wang Y, Hang B, Zou X, Mao J . A novel gene expression-based prognostic scoring system to predict survival in gastric cancer. Oncotarget. 2016; 7(34):55343-55351. PMC: 5342421. DOI: 10.18632/oncotarget.10533. View

16.

Wang L, Cao C, Ma Q, Zeng Q, Wang H, Cheng Z . RNA-seq analyses of multiple meristems of soybean: novel and alternative transcripts, evolutionary and functional implications. BMC Plant Biol. 2014; 14:169. PMC: 4070088. DOI: 10.1186/1471-2229-14-169. View

17.

Lee K, Park S, Hamajima N, Tajima K, Choi J, Noh D . Genetic polymorphisms of interleukin-1 beta (IL-1B) and IL-1 receptor antagonist (IL-1RN) and breast cancer risk in Korean women. Breast Cancer Res Treat. 2005; 96(2):197-202. DOI: 10.1007/s10549-005-9079-6. View

18.

Koc E, Haciosmanoglu E, Claudio P, Wolf A, Califano L, Friscia M . Impaired mitochondrial protein synthesis in head and neck squamous cell carcinoma. Mitochondrion. 2015; 24:113-21. DOI: 10.1016/j.mito.2015.07.123. View

19.

Sorlie T, Tibshirani R, Parker J, Hastie T, Marron J, Nobel A . Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A. 2003; 100(14):8418-23. PMC: 166244. DOI: 10.1073/pnas.0932692100. View

20.

Huang D, Sherman B, Lempicki R . Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009; 4(1):44-57. DOI: 10.1038/nprot.2008.211. View